← Open Payments lookup

LEANNE GALVAN: Open Payments

NPI 1730648759 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,934 in 110 payments from 31 companies in 2025. Trend: 2023 $1,451 · 2024 $1,620 · 2025 $1,934

Food & beverage: $1,889Education: $45
CompanyPaymentsAmount
ABBVIE INC.26$379
Amgen Inc.11$242
Lilly USA, LLC7$147
AstraZeneca Pharmaceuticals LP8$143
PFIZER INC.11$139
Novo Nordisk Inc5$81
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$78
HARMONY BIOSCIENCES LLC4$70
Boehringer Ingelheim Pharmaceuticals, Inc.4$64
Abbott Laboratories2$48

Products named: VRAYLAR, REPATHA, UBRELVY, NURTEC ODT, XIFAXAN, QULIPTA, WAKIX, OTEZLA.

Industry payments across NE — which companies pay providers there.